Acelrx Pharmaceuticals reported $1.42M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acelrx Pharmaceuticals ACRX:US $ 1.42M 2.02M
Baxter International BAX:US $ 1343M 101M
Becton, Dickinson and BDX:US $ 2254M 93M
Intra Cellular Therapies ITCI:US $ 20.21M 2.2M
Johnson & Johnson JNJ:US $ 16088M 343M
Pfizer PFE:US $ 14163M 2178M
Smiths SMIN:LN 474M 33M
Teva Pharmaceutical TEVA:IT 1.9B 25M
Xeris Pharmaceuticals Inc XERS:US $ 7.84M 2.32M
Zogenix ZGNX:US $ 21.32M 3.75M